Patient advocacy organizations look to partner with pharma companies

June 14, 2022

Patient advocacy organizations are looking to partner with pharmaceutical companies, offering resources and expertise to maximize the impact and efficiency of their therapeutic R&D programs. It’s a message that these groups want to drive home to pharma at the 2022 Biotechnology Innovation Organization (BIO) International Convention in San Diego.

"There is an incredibly unique vantage point that nonprofits and advocacy organizations can serve," Danielle Kerkovich, PhD, director of research development and partnerships for the International Fibrodysplasia Ossificans Progressiva Association (IFOPA), told ScienceBoard.net. "We do have resources that are incredibly valuable to de-risking some of these programs so that pharmaceutical companies can ultimately be successful."

Kerkovich was a panelist for the June 14 panel at BIO 2022 titled, "Partnering for Progress: Collaborating With Patient Organizations To Advance Therapy Development and Maximize Patient Benefit."

IFOPA maintains the world's only patient registry for patients with Fibrodysplasia Ossificans Progressiva (FOP), a rare genetic disorder that causes soft tissues to transform permanently into bone. Currently, six pharma companies have access to the real-world data in the patient registry.

"It's also important that we provide this go-between between drug developers and academic institutions that are working on advancing programs and the patients, to make sure that the two sides are considering one another's perspectives," said Michelle Davis, executive director of IFOPA. "One of the activities that we participate in is making the [patient] community aware about the drug development process and about the process of clinical studies and trials."

Watch the video below to learn more.


How to develop a sustainable portfolio for cell, gene therapy platforms
Michael Retterath, a Biotechnology Innovation Organization International Convention 2022 panelist and chief business officer at Spark Therapeutics, spoke...
Biotech industry execs, not scientists, remain male-dominated
A panel at the 2022 Biotechnology Innovation Organization International Convention will explore how to close the gender gap in the biotech industry and...
The ‘voice of the patient’ needs to be heard in clinical trials: study
Patient recruitment and retention are among the biggest challenges facing clinical research, particularly in studies targeting rare diseases that have...
New era of non-viral DNA-delivered gene therapy seen emerging
Advancements in nucleic acid-encoded therapeutics over the past decade have sparked the emergence of a new era in non-viral DNA-delivered gene therapy,...
Biotech innovator recounts decades-long journey to create drug discovery technology
Dr. Stan Crooke, PhD, founder, chairman, and chief executive officer of RNA therapy company Ionis Pharmaceuticals, pioneered development of the antisense...
Biotech industry to gather at BIO International Convention in San Diego
More than 11,000 attendees from around the globe will be in San Diego, June 13-16, for the 2022 Biotechnology Innovation Organization (BIO) International...

Copyright © 2022 scienceboard.net

Last Updated 6/14/2022 12:25:44 PM